parkinson's disease retatrutide clinical trial drug therapies in the pipeline: 2023 update Parkinson's Disease Drug Therapies in

There is a need to conduct randomized controlled trials with large sample sizes to investigate the use of GLP-1s with the indication to treat mental illness, Breit said

Recent Update of Renin-Angiotensin-Aldosterone System in the Pathogenesis of Hypertension

Nauck MA, Petrie JR, Sesti G, et al

Chand at the Cleveland Clinic Weston said another side effect can be a reduction in bone density and an increased fracture risk

Instead, these FDA-approved medications work primarily by reducing appetite, slowing gastric emptying, and decreasing caloric intake

The overall positivity rate for drug use in the Army was recorded at 1.06%